Arkolith/Insider Trading/ADIL/Form 4

Stilley William B. III

Chief Executive Officer, Director, 10% OwnerADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Dec 1, 2021
Net Buying
Open-Market Buys
$55K
Open-Market Sells
$0
Net Open-Market Flow
$55K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2021Buy(P)11K$2.75$29K938K
Nov 29, 2021Buy(P)10K$2.59$26K927K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-062729) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML